Livingstone Health Holdings Management

Management criteria checks 2/4

Livingstone Health Holdings' CEO is Wilson Tay, appointed in Jan 2021, has a tenure of 3.83 years. directly owns 7.9% of the company’s shares, worth SGD1.02M. The average tenure of the management team and the board of directors is 3.8 years and 5 years respectively.

Key information

Wilson Tay

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	3.8yrs
CEO ownership	7.9%
Management average tenure	3.8yrs
Board average tenure	5yrs

Recent management updates

Recent updates

CEO

Wilson Tay (45 yo)

3.8yrs

Tenure

Dr. Ching Yit Tay is also known as Wilson, M.B.B.S. (Singapore), M.Med Anaes (Singapore), F.A.M.S. (Anaes), F.I.P.P. (WIP, USA), C.I.P.S. (WIP, USA) serves as Chief Executive Officer at Livingstone Health...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Ching Yit Tay	Executive Director & CEO	3.8yrs	no data	7.9% SGD 1.0m
Qingyuan Wong	Chief Financial Officer	less than a year	no data	0.74% SGD 95.8k
Yung Sern Ng	Chief Commercial Officer & Executive Director	4.8yrs	no data	1.71% SGD 220.5k
Chua Hshan Cher	Deputy CEO & Head of Family Medicine	no data	no data	0.65% SGD 84.3k
Jong Yuh Gn	Secretary	no data	no data	no data

3.8yrs

Average Tenure

Experienced Management: PRH's management team is considered experienced (3.8 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Ching Yit Tay	Executive Director & CEO	3.8yrs	no data	7.9% SGD 1.0m
Yung Sern Ng	Chief Commercial Officer & Executive Director	less than a year	no data	1.71% SGD 220.5k
Heng Fong	Lead Independent Non-Executive Director	6.3yrs	no data	no data
Wing Kwan Teh	Non Independent & Non Executive Chairman	6.4yrs	no data	4.65% SGD 598.5k
Jun Xiong Lim	Independent Non-Executive Director	3.8yrs	no data	no data
Yu Meng Chan	Independent Non-Executive Director	6.3yrs	no data	no data

5.0yrs

Average Tenure

51.5yo

Average Age

Experienced Board: PRH's board of directors are considered experienced (5 years average tenure).

Livingstone Health Holdings Management

Management criteria checks 2/4

Key information

Recent management updates

High number of new directors

Livingstone Health Holdings Limited, Annual General Meeting, Jul 31, 2024

Insufficient new directors

Livingstone Health Holdings Limited, Annual General Meeting, Jul 27, 2023

Livingstone Health Holdings Limited Announces the Cessation of Mr. Leow Chin Yew as Group Financial Controller

Livingstone Health Holdings Limited Announces Cessation of Cindy Lau Sok Mui (Liu Shumei) as Head of Operations

Recent updates

Livingstone Health Holdings Limited to Report First Half, 2025 Results on Nov 14, 2024

New major risk - Market cap size

High number of new directors

Livingstone Health Holdings Limited, Annual General Meeting, Jul 31, 2024

Full year 2024 earnings released: S$0.65 loss per share (vs S$0.002 profit in FY 2023)

New minor risk - Financial data availability

Livingstone Health Holdings Limited to Report Fiscal Year 2024 Results on May 30, 2024

Livingstone Health Holdings Limited has filed a Follow-on Equity Offering in the amount of SGD 1.574235 million.

New minor risk - Shareholder dilution

Livingstone Health Holdings Limited has completed a Follow-on Equity Offering in the amount of SGD 1.500039 million.

Livingstone Health Holdings Limited has filed a Follow-on Equity Offering in the amount of SGD 1.500039 million.

Livingstone Health Holdings Limited has filed a Follow-on Equity Offering in the amount of SGD 1.500039 million.

Insufficient new directors

New major risk - Market cap size

Livingstone Health Holdings Limited to Report First Half, 2024 Results on Nov 14, 2023

New major risk - Market cap size

New minor risk - Earnings quality

Full year 2023 earnings released: EPS: S$0.002 (vs S$0.009 in FY 2022)

Livingstone Health Holdings Limited, Annual General Meeting, Jul 27, 2023

Full year 2023 earnings released: EPS: S$0.002 (vs S$0.01 in FY 2022)

Livingstone Health Holdings Limited Announces the Cessation of Mr. Leow Chin Yew as Group Financial Controller

First half 2023 earnings released: EPS: S$0.002 (vs S$0.006 in 1H 2022)

Livingstone Health Holdings Limited Announces Cessation of Cindy Lau Sok Mui (Liu Shumei) as Head of Operations

Livingstone Health Holdings Limited Proposes First and Final One-Tier Tax Exempt Dividend for the Financial Year Ended 31 March 2022, Payable on August 29, 2022

Livingstone Health Holdings Limited Proposes First and Final One-Tier Tax Exempt Dividend, Payable on 11 August 2022

Head of Orthopaedic Surgery recently bought S$4.8m worth of stock

Livingstone Health Holdings Limited Proposes Final Dividend

Livingstone Health Holdings Limited Appoints Chua Hshan Cher as Deputy Chief Executive Officer

Livingstone Health Launches One-Stop Health Screening Centre Ardennes Healthcare Pte Ltd

Livingstone Health Holdings Limited to Report Fiscal Year 2021 Results on May 30, 2021

Livingstone Health Holdings Limited Appoints Lim Jun Xiong Steven as Independent and Non-Executive Director

Livingstone Health Ltd. completed the acquisition of Citicode Ltd. (SGX:5FH) in a reverse merger transaction.

CEO

Tenure

Leadership Team

Average Tenure

Board Members

Average Tenure

Average Age